» Authors » Rick Nichols

Rick Nichols

Explore the profile of Rick Nichols including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 102
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Camargos V, Rossi S, Juelich T, Smith J, Vasilakis N, Freiberg A, et al.
Viruses . 2024 Aug; 16(8). PMID: 39205155
Filoviruses, like the Marburg (MARV) and Ebola (EBOV) viruses, have caused outbreaks associated with significant hemorrhagic morbidity and high fatality rates. Vaccines offer one of the best countermeasures for fatal...
2.
Cao W, He S, Liu G, Schulz H, Emeterio K, Chan M, et al.
NPJ Vaccines . 2023 Jun; 8(1):91. PMID: 37301890
Recombinant vesicular stomatitis viruses (rVSVs) engineered to express heterologous viral glycoproteins have proven to be remarkably effective vaccines. Indeed, rVSV-EBOV, which expresses the Ebola virus (EBOV) glycoprotein, recently received clinical...
3.
Ilchmann H, Samy N, Reichhardt D, Schmidt D, Powell J, Meyer T, et al.
J Infect Dis . 2022 Nov; 227(10):1203-1213. PMID: 36408618
Background: Although modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccination is approved for smallpox and monkeypox prevention, immunological persistence and booster effects remain undescribed. Methods: Participants naive to smallpox vaccination were randomized...
4.
Zhu W, Liu G, Cao W, He S, Leung A, Stroher U, et al.
Vaccines (Basel) . 2022 Jul; 10(7). PMID: 35891170
Marburg virus (MARV) is a negative-sense, single-stranded RNA virus that belongs to the family. Despite having caused numerous outbreaks of severe hemorrhagic fever with high case fatality rates, there are...
5.
Grant-Klein R, Antonello J, Nichols R, Dubey S, Simon J
Am J Trop Med Hyg . 2021 Mar; 104(5):1751-1754. PMID: 33782211
Gamma irradiation (GI) is included in the CDC guidance on inactivation procedures to render a group of select agents and toxins nonviable. The Ebola virus falls within this group because...
6.
Antonello J, Grant-Klein R, Nichols R, Kennedy S, Dubey S, Simon J
Vaccine . 2020 Jun; 38(31):4885-4891. PMID: 32499064
The recombinant vesicular stomatitis virus - Zaire Ebola virus envelope glycoprotein (rVSVΔG-ZEBOV-GP) vaccine is a live recombinant vesicular stomatitis virus (VSV) where the VSV G protein is replaced with ZEBOV-GP....
7.
Halperin S, Das R, Onorato M, Liu K, Martin J, Grant-Klein R, et al.
J Infect Dis . 2019 Sep; 220(7):1127-1135. PMID: 31505665
Background: This double-blind study assessed immunogenicity, lot consistency, and safety of recombinant vesicular stomatitis virus-Zaire Ebola virus envelope glycoprotein vaccine (rVSVΔG-ZEBOV-GP). Methods: Healthy adults (N = 1197) were randomized 2:2:2:2:1...
8.
Grant-Klein R, Antonello J, Nichols R, Dubey S, Simon J
Am J Trop Med Hyg . 2019 Jun; 101(1):207-213. PMID: 31162004
rVSVΔG-ZEBOV-GP vaccine is a live recombinant (r) vesicular stomatitis virus (VSV), where the VSV G protein is replaced with the Zaire Ebola virus (ZEBOV) glycoprotein (GP). For vaccine immunogenicity testing,...
9.
Coller B, Blue J, Das R, Dubey S, Finelli L, Gupta S, et al.
Vaccine . 2017 Jun; 35(35 Pt A):4465-4469. PMID: 28647166
The 2014-2016 Ebola outbreak caused over 28,000 cases and 11,000 deaths. Merck & Co. Inc., Kenilworth, NJ USA and NewLink Genetics are working with private and public partners to develop...